🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy cardiologist just high-fived me at my checkup lol — what worked for you? Page 2

My cardiologist just high-fived me at my checkup lol — what worked for you?

DataDave Thu, Aug 7, 2025 at 9:26 PM 11 replies 1,375 viewsPage 2 of 3
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Aug 8, 2025 at 12:53 AM#6
Dr.RenalNash said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

Last edited: Aug 8, 2025 at 1:53 AM
5 8matt_MKE, Dr.ReproEndo, lucas_SP_BR and 2 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Aug 8, 2025 at 2:14 AM#7
DataDave said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.
DataDave said:
...cardiovascular risk is just another fad...

I understand the skepticism — we've all seen "miracle" weight loss solutions come and go. But consider what makes GLP-1 agonists different:

  • Phase 3 RCTs with thousands of participants (not 20-person pilot studies)
  • Published in NEJM, JAMA, Lancet (not press releases)
  • Replicated across multiple independent research groups
  • Proven cardiovascular and renal benefits beyond weight loss
  • Biological mechanism fully characterized at the receptor level

This isn't a fad — it's a new drug class supported by the highest level of clinical evidence. The comparison to past fads is understandable but inappropriate.

6 9tom_AK, josh_phd_bmore, roxy_nash and 3 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Aug 8, 2025 at 3:35 AM#8
COA_Karl said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off amlodipine entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

7 10BrianDallas92, labquiet_amy, emily_PDX and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Aug 8, 2025 at 4:56 AM#9

One thing that is still open after SleepDoc_PDX’s answer:

What did you change at the same time, and can you separate the two now?

8 11Dr.PathRoch, mona_PHX, andrew_nyc and 5 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Aug 8, 2025 at 11:25 AM#10
CarlaRPh_TPA said:
Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off amlodipine entirely!

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

  • NT-proBNP: 70 pg/mL (normal, cardiac function preserved)
  • Lp(a): 50 nmol/L (genetic, unchanged — expected)
  • ApoB: dropped from 140 to 95 mg/dL (excellent response)
  • Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

14 14Dr.GutHealth, amsterdam_pete, LondonLisa and 11 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register